PATENT CLAIM ANALYSIS

Application Number: 16117375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "648000"]

Abstract:
An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.

Claim (Index 18):
The method of  claim 12  wherein the oral dosage form is a lyophilized tablet.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14973759', '15823636', '15387317', '14697891', '12638070']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7688715029701273
- 35 USC 102 Novelty (BERT): 0.5075518046771206
- Combined Prediction Score: 0.7427395331408266
- Mean Citation Score: 215.47927400000003
- Max Citation Score: 270.94516
- Similarity Product: 197.820526992178

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test